Skip to content

Effects of percutaneous electrical acupoint stimulation on perioperative neurological function and prognosis in patients undergoing laparoscopic radical gastrointestinal tumor resection

Effects of percutaneous electrical acupoint stimulation on perioperative neurological function and prognosis in patients undergoing laparoscopic radical gastrointestinal tumor resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072508
Enrollment
Unknown
Registered
2023-06-15
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors of the gastrointestinal tract

Interventions

Before surgery, percutaneous acupoint electrical stimulation was performed for 30min + propofol + refentanil + sufentanil + sevoflurane group:The preoperative percutaneous acupoint electrical stimulat
Propofol + refentanil + sufentanil + sevoflurane + postoperative percutaneous acupoint electrical stimulation group for 30min:Propofol + refentanil + sufentanil + sevoflurane + postoperative transcuta
Propofol + refentanil + sufentanil + sevoflurane group:Propofol + refentanil + sufentanil + sevoflurane

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing laparoscopic radical resection of gastrointestinal tumors in an elective period; (2) ASA grade I. ~ III; (3) Age= 65 years old; (4) Primary school education level or above; (5) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Emergency surgery; (2) Serious heart, liver, kidney and other organic diseases, ASA = V grade; (3) Patients with mental disorders, mental retardation, inability to communicate, inability to cooperate or coma; (4) Those who are allergic to narcotic drugs, analgesic drugs or addicted to narcotic drugs; (5) Patients with local skin infection and breakage.

Design outcomes

Primary

MeasureTime frame
3D-CAM;NIHSS;CAM-CR;Modified Rankin Scale;MMSE Scale;Barthel index Scale;

Secondary

MeasureTime frame
IL-6;CRP;BDNF;S100ß;C3b;

Countries

China

Contacts

Public ContactJingwen Wei

The First Affiliated Hospital of Guangxi Medical University

shaqiuyy04@126.com+86 771 535 6250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026